BioSante Pharmaceuticals, Inc.
Biotech Specialty Pharma
111 Barclay Boulevard
Lincolnshire, IL 60069 USA
phone: 847-478-0500
fax: 847-478-9152
Symbol BPA
Exchange AMEX
Founded 0
Employees
www.biosantepharma.com
Research Sector Biotech Specialty Pharma
Summary Description
Transdermal gel hormone replacement products.
Management
Stephen M. Simes, President and CEO; Phillip B. Donenberg, CFO
Ownership
Financials Mkt Cap :53


* numbers in thousands

 
Keywords
hormone therapy, menopause, osteoporosis, impotence, sex drive

Comment | Printable Version | Mar. 05, 2007
If you work for BioSante Pharmaceuticals, Inc. and want to update this profile, click here

Description
BioSante Pharmaceuticals, Inc. is developing and commercializing a pipeline of novel pharmaceuticals and transdermal gel hormone replacement products to treat hormone deficiencies in both men and women.
Products / Services
BioSante's hormone therapy products are gel formulations for transdermal administration that deliver bioidentical estradiol and testosterone.
Market / Customers
Symptoms treated with hormone therapy in men include impotence, diminished sex drive, muscle weakness and osteoporosis. Symptoms in menopausal women include hot flashes, vaginal atrophy, decreased libido and osteoporosis.


2008-11-22-203